Overview

Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that cognitive remediation will be superior to the active control group on the change from baseline to study end point of cognitive remediation phase on both co-primary outcome measures (standardized composite MATRICS score and Cognitive Assessment Interview).
Phase:
Phase 3
Details
Lead Sponsor:
New York State Psychiatric Institute
University of California, Los Angeles
Treatments:
Lurasidone Hydrochloride